This is a OPEN AI summary of the Tim Ferriss Podcast #610- visit www.TinyTim.blog for more AI summaries, or www.Tim.blog for the official Tim Ferriss Podcasts.

Matt Kaeberlein is a professor of laboratory medicine and pathology at the University of Washington School of Medicine. His research interests are focused on understanding the biological mechanisms of aging. He is the founding director of the University of Washington Healthy Aging and Longevity Research Institute, the director of the NIH Nathan Shock Center of Excellence in the Basic Biology Of Aging at University of Washington, and the founder and co-director of the Dog Aging Project. The Dog Aging Project is a study of over 40,000 pet dogs across the United States to learn about the genetic and environmental factors that influence aging. The project has two parts: a longitudinal study of aging, and a clinical trial testing a drug to slow or reverse aging. The concept of "healthspan" refers to the period of time during which a person is in good health. This concept is becoming increasingly popular as people realize that health decline is a natural part of aging. However, there are ways to slow down the decline, and rapamycin is one example of a drug that has shown promise in this area.

Matt Kaeberlein discusses his experience with frozen shoulder and how rapamycin helped to reduce the inflammation and pain. Rapamycin is a drug typically used to prevent organ rejection in transplant patients, but it has also been shown to be effective in reducing age-related inflammation. Chronic inflammation that is not caused by infection is a problem that increases with age, and is referred to as "inflammaging." Senolytics are a class of molecules that are designed to kill senescent cells, with the goal of reducing chronic inflammation with age. The idea that senescent cells can be eliminated to improve health is a sexy one, but it turns out that it's probably not that easy. Rapamycin has been shown to be effective at shutting off the inflammatory signals that these cells produce, and it may also indirectly help to clear senescent cells from the body.

Rapamycin is a drug that is used to prevent organ transplant rejection and to treat some types of cancer. It is also used for some rare disorders that are caused by hyperactivation of mTOR. Studies in mice have shown that rapamycin treatment can improve immune system function. Rapamycin has been shown to improve the function of stem cells in some tissues, and this may be due to its ability to reduce chronic inflammation. Dr. Matt Kaeberlein is a researcher working on the Dog Aging Project, a study investigating the effects of the drug rapamycin on aging in dogs.

Researchers are testing whether the anti-aging drug rapamycin can increase lifespan and healthspan in dogs. So far, the trial has been successful, with no adverse effects reported. Rapamycin has been shown to have beneficial effects on various tissues in both mice and rats, including the brain, where it reduces inflammation and improves metabolic function. Matt Kaeberlein and Tim Ferriss discuss the potential for rapamycin to increase lifespan by up to 25 percent. They suggest that targeting the biology of aging is a valid concern.

In this conversation, Tim Ferriss and Matt Kaeberlein discuss the function and significance of 17 alpha estradiol, a hormone that has been shown to extend lifespan in males. Kaeberlein notes that the mechanism by which it does this is still unknown, but that it is likely working to prevent cancer and other age-related diseases. Deprenyl is a drug that has been shown to extend lifespan in rodents and dogs, but has not been studied extensively in humans. Matt Kaeberlein is interested in this drug and its potential to help people live longer, healthier lives. However, the lack of available data makes it difficult to determine whether or not deprenyl is effective and safe for human use.

In this podcast, Tim Ferriss interviews Matt Kaeberlein, a veterinarian and researcher in the field of aging. They discuss the potential benefits of time-restricted feeding for dogs, as well as the risks and uncertainties associated with this and other anti-aging interventions.

Dr. Matt Kaeberlein discusses the recently announced $1 billion donation to the study of aging by billionaires Peter Thiel and Jeff Bezos. He explains that the donation will be split between grants to nonprofit organizations and investments in for-profit ventures. He also discusses the challenges of conducting research on aging, including the need to attract researchers from outside the field.

The main issues with conducting clinical trials for aging-related issues are the long timeframe required to see results, and the lack of funding for such trials. One solution is the comorbidity study, which looks at the frequency of age-related disease diagnoses and the length of time between diagnoses. Another solution is to focus on shorter-term functional measures of aging.

In this conversation, Matt Kaeberlein and Tim Ferriss discuss the idea that sirtuins may be therapeutic targets for aging. Kaeberlein shares that he has not given up on sirtuins as therapeutic targets for aging, despite the lack of evidence that they are effective at extending lifespan in mammals. They discuss the difficulty of reading scientific papers for those without a technical background, and how this can lead to misinformation being spread. Kaeberlein recommends Peter Attia's blog series "Studying Studies" as a resource for learning how to evaluate scientific studies.

Resveratrol is a dirty drug that has been studied extensively for its effects on aging. However, the media has largely ignored the drug in recent years. A recent meta-analysis of resveratrol's effect on aging found that there is no consensus across experiments - some show an effect, while most show no effect. Tim Ferriss became interested in the potential endurance-enhancing effects of resveratrol in 2008, but has found no significant effects. The 4-Hour Body is a book about working with sports scientists to improve one's physical performance. The author, Tim Ferriss, experimented with taking large doses of resveratrol, a compound found in red wine, and found that it caused him terrible joint pain. He eventually stopped taking it and now cautions others that there are always downsides to any biological intervention, no matter how promising it may seem.

The speaker discusses the potential side effects of rapamycin, a drug used to treat aging. They note that while the drug can have some uncomfortable side effects, the consequences of doing nothing to maintain one's health as they age are much worse. The goal of science is to develop the best model possible for whatever it is that is being studied. This is true in almost every scientific discipline, including biology and aging. The speaker discusses the importance of being skeptical of one's models and testing where the model does not fit in order to get closer to the truth.

In this conversation, Tim Ferriss and Matt Kaeberlein discuss the field of geroscience and the exciting new discoveries being made in the field. They also discuss the challenges of dealing with the noise and misinformation surrounding geroscience.

610 https://tim.blog/2022/07/27/matt-kaeberlein-life-extension/